Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

Delayed Data
As of Oct 20
 +1.95 / +1.64%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 120.00, with a high estimate of 213.00 and a low estimate of 95.00. The median estimate represents a -0.83% decrease from the last price of 121.01.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 406.45%
Growthannually -31.54%


Growthquarterly -4.09%
Growthannually 2.29%
Key to the earnings and sales forecast charts.